A 70-year-old with HFrEF (EF 25%) on ARNI, beta-blocker, MRA, SGLT2i remains NYHA III. Which therapy may reduce HF hospitalization in high-risk patients recently decompensated?ANSAIDBDPP-4 inhibitorCSGLT2i remains NYHA III. Which therapy may reduce HF hospitalization in high-risk patients recently decompensated?DVericiguatEIvabradine with HR 60/minCheck my answer